Aspirin and the prevention of cardiovascular disease in chronic kidney disease: time to move forward?

摘要

Chronic kidney disease (CKD) is a common global public health problem. More than 500 million people worldwide-about 1 in 10 adults-have some form of kidney damage (1). In the U.S., an estimated 20 million people have CKD, and this number is believed to be increasing exponentially within an aging population (2).